 |
13 Diseases |  |
0 Trials |
|
0 Trials |  |
7 News |  |
- | anagrelide CR (GALE-401) / SELLAS Life Sciences
Trial completion, Trial primary completion date: A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders (clinicaltrials.gov) - Feb 27, 2017
P2, N=18, Completed, Sponsor: Galena Biopharma, Inc.
Active, not recruiting --> Completed | Trial primary completion date: Jan 2016 --> May 2016
- | anagrelide CR (GALE-401) / SELLAS Life Sciences
Enrollment closed: A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders (clinicaltrials.gov) - Nov 28, 2014
P2, N=20, Active, not recruiting, Sponsor: Galena Biopharma, Inc.
Active, not recruiting --> Completed | Trial primary completion date: Jan 2016 --> May 2016 Recruiting --> Active, not recruiting
- | anagrelide CR (GALE-401) / SELLAS Life Sciences
Enrollment open: A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders (clinicaltrials.gov) - Jun 17, 2014
P2, N=20, Recruiting, Sponsor: Galena Biopharma, Inc.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | anagrelide CR (GALE-401) / SELLAS Life Sciences
New P2 trial: A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders (clinicaltrials.gov) - Apr 22, 2014
P2, N=20, Not yet recruiting, Sponsor: Galena Biopharma, Inc.